Press Release: Vitalist Reports Second Quarter 2027 Financial Results

Dow Jones11-18

CALGARY, Alberta, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSX-V: VITA.V; OTCQB: VTLSF) ("Vitalist", "we", "our", or the "Company"), a wearable operating-system focused technology company, today announced its financial results for the six months ended September 30, 2026 ("Q2 2027"). The related financial statements and accompanying notes, and Management's Discussion and Analysis for Q2 2027 ("MD&A") are available on SEDAR+ at www.sedarplus.ca and on the Vitalist's website at www.vitalist.co.

All dollar amounts in this press release are expressed in the Canadian dollars.

Q2 2027 Highlights

   -- Revenue in the three month period ended September 30, 2026 decreased by 
      $1.77 million reflecting a decrease of 92% compared to the corresponding 
      period of the prior year. Revenue decreased by $2.50 million reflecting a 
      decrease of 73% in the six month period ended September 30, 2026 as 
      compared to the corresponding period of the prior year. The decrease is 
      related to lower sales velocity at retail and distributors not needing to 
      replenish inventory given their current stock. This was partially offset 
      by the unwinding of previously estimated B2B refund and sales inducement 
      provisions. 
 
   -- The gross profit margin in the three month period ended September 30, 
      2026 was negligible, as compared to 40% in the corresponding period of 
      the prior year, a decrease of $0.78 million. The decrease was due to 
      relatively higher refund provision adjustments than in the comparable 
      period. The gross profit margin for the six month period ended September 
      30, 2026 increased to 48% as compared to 36% for the corresponding period 
      of the prior year. The increase is due to improved product margin 
      economics and the partial unwinding of refund, warranty and sales 
      inducement provisions on sales. 
 
   -- The Company incurred a net loss of $2.45 million and $3.56 million for 
      the three and six months ended September 30, 2026 respectively. In the 
      prior year the Company had recorded a net income of $0.15 million and a 
      net loss of $0.31 million for the six months ended September 30, 2025, 
      respectively. The increase in net loss was primarily driven by a decrease 
      in revenue, coupled with an increase in operating expenses related to the 
      acquisition of Somatix, Inc. 
 
   -- Operating cash outflows were approximately $5.60 million for the six 
      month ended September 30, 2026, compared with approximately $2.44 million 
      in the six month period ended September 30, 2025. The increase was 
      attributable to a temporary increase to operating expenditures from the 
      newly acquired Somatix entity, one time transaction costs and decreased 
      revenue. 

Outlook

Looking forward, Vitalist Inc. remains focused on building its presence across the consumer and enterprise health markets. The Company is continuing to execute on its exclusive five-year brand partnership with Reebok, beginning with the November 2026 launch of the Reebok Kinetic smartwatch. Running on Vitalist's proprietary operating system, VitalOS(TM), the release will demonstrate the platform's core functionality, up to 7-day battery life, and hardware compatibility, providing a commercial use case to support potential future software licensing discussions. Concurrently, following the acquisition of remote patient monitoring business Somatix, Inc., Vitalist is working to broaden its portfolio into the medical wearables segment. By integrating Somatix's technology into VitalOS(TM), the Company intends to develop recurring revenue opportunities across enterprise healthcare and consumer channels over time.

"As we move through the fiscal year, our focus has been on broadening both our physical and digital distribution footprint," said Kalvie Legat, CEO of Vitalist. "We have added placement across several regional and national retail formats, including travel centers, specialty storefronts, and off-price outlets. Alongside our engagement with Pattern Inc. to support our e-commerce operations across major online marketplaces, these channels are intended to provide a wider distribution base for upcoming quarters."

Selected Financial Information

 
                    Three months ended       Six months ended 
                      September 30,          September 30, 
                   2026(2)        2025(1)        2026      2025(1) 
                  (revised)      (revised)                 (revised) 
                      $              $            $               $ 
Total revenue      164,624        1,937,930      921,430      3,417,812 
Gross profit           511          779,905      441,945      1,236,752 
Net loss        (2,453,422)         152,196   (3,562,494)      (312,332) 
Net cash used 
 in operating 
 activities     (2,490,263)         119,729   (5,595,316)    (2,444,139) 
Basic & 
 diluted loss 
 per share           (0.04)            0.00        (0.06)         (0.01) 
(1)           Comparative figures for the three and six months ended 
               September 30, 2025 have been revised to reflect the 
               correction of prior-period revenue and cost of products 
               misstatements. Refer to "Correction of Prior-Period 
               Misstatements" under the "BASIS OF PRESENTATION" section 
               and Note 2(c) of the Q2 FY27 Financial Statements. 
(2)           Comparative figures for the prior quarter ended June 
               30, 2026, have been revised to reflect the correction 
               of prior-period gains and accretion. Refer to "Correction 
               of Prior-Period Misstatements" under the "BASIS OF 
               PRESENTATION" section and Note 2(d) of the Q2 FY27 
               Financial Statements. 
 
 
                                          September 30,  March 31, 
As at                                          2026         2026 
                                                $            $ 
----------------------------------------  -------------  --------- 
Total assets                                 10,582,052  1,039,063 
Total non-current financial liabilities      11,369,593  6,645,271 
----------------------------------------  -------------  --------- 
 
 

About Vitalist Inc.

Vitalist Inc. is an innovative technology provider that helps brands build better products. Through VitalOS(TM), brands create seamlessly connected devices and applications that adapt to each user. By uniting hardware and software with intelligent analytics, we're building an ecosystem of personalized solutions that enhance human potential.

For more information visit: www.vitalist.co | Investor Materials | LinkedIn

Join the Vitalist distribution list: www.vitalist.co/investors

Investor Relations Contact

For further information about Vitalist Inc. please contact:

Kalvie Legat, CEO

Vitalist

+1 (403) 560-9635

ir@vitalist.ca

Walter Frank

IMS Investor Relations

+1 (203) 972-9200

vitalist@imsinvestorrelations.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Information

This press release contains "forward-looking information" within the meaning of applicable Canadian securities laws. In general, forward-looking information is disclosure about future conditions, courses of action, and events, including information about prospective financial performance or financial position. The use of any of the words "anticipates", "believes", "expects", "intends", "plans", "will", "would", and similar expressions are intended to identify forward-looking information. Forward-looking statements included or incorporated by reference in this press release include, without limitation, with respect to:

   -- the ability of the Company to continue as a going concern; 
 
   -- the impact on the Company of the voluntary assignment into bankruptcy of 
      eBuyNow eCommerce Ltd. ("EBN"), a wholly-owned Canadian subsidiary of the 
      Company, which was filed by EBN on June 27, 2023 pursuant to the 
      Bankruptcy and Insolvency Act (R.S.C., 1985, c. B-3) (the "Act") 
      (collectively, the "Bankruptcy"); 
 
   -- the commercial success of, and reliance upon, the five-year brand 
      licensing agreement with Reebok as the Company's primary consumer 
      hardware vehicle; 
 
   -- the impact on the Company of the acquisition of Somatix, Inc. 
      ("Somatix"); 
 
   -- the effects of global supply constraints on the Company and the 
      likelihood that such constraints will continue to occur and impact the 
      Company; 
 
   -- the plans of the Company for the Reebok (defined below) product category, 
      the status of the Reebok product category relative to those plans, and 
      the anticipated timing and costs to advance the Reebok product category; 
 
   -- the plans of the Company for the Vitalist (defined below) product 
      category, the status of the Vitalist product category relative to those 
      plans, and the anticipated timing and costs to advance the Vitalist 
      product category; 
 
   -- the plans of the Company to terminate certain product lines and product 
      categories; 
 
   -- the strategies of the Company for customer retention and growth; 
 
   -- anticipated demand for the products and services of the Company, and its 
      ability to meet that demand; 
 
   -- the Company's intent to maintain a flexible capital structure; 
 
   -- the ability of the Company to generate sufficient cash to maintain its 
      capacity and fund its growth and development; 
 
   -- fluctuations in the liquidity of the Company; 
 
   -- the ability of the Company to meet its obligations as they become due; 
 
   -- the plans of the Company for remedying its working capital deficiency; 
 
   -- the need for the Company to pursue additional sources of financing and 
      the ability of the Company to obtain such additional sources of 
      financing; 
 
   -- capital expenditures not yet committed, but required, to maintain the 
      capacity of the Company and fund its growth and development; 
 
   -- fluctuations in the capital resources of the Company; 
 
   -- the sources of financing that the Company has arranged, but not yet used; 
      and 
 
   -- the plans of the Company to reduce general and administrative expenses. 

The forward-looking information is based on certain key expectations and assumptions, including the continuance of manufacturing operations at the Company's partner factories in Asia, the timing of product launches, shipments and deliveries, forecast sales price and sales volumes of the Company's products and the ability of the Company to secure additional sources of financing in the future.

There can be no assurance that the Company will be able to secure additional financing in the future in a timely manner or at all. If the Company fails to secure additional financing, the Company may have insufficient liquidity and capital resources to operate its business resulting in material uncertainty regarding the Company's ability to meet its financial obligations as they become due and continue as a going concern.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company cannot give any assurance that it will prove to be accurate. By its nature, forward-looking information is subject to various risks, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed in this MD&A. Such risks and uncertainties include, without limitation:

   -- there is the potential for litigation to arise from creditors in 
      connection with the Bankruptcy resulting in contingent liabilities and 
      additional legal costs to the Company; 
 
   -- certain liabilities of EBN and its subsidiaries may not be extinguished 
      in connection with the Bankruptcy; 
 
   -- the Company may fail to obtain, maintain, or comply with required medical 
      device regulatory approvals, clearances, or clinical standards for its 
      remote patient monitoring solutions; 
 
   -- the Company faces enhanced compliance burdens, penalties, and litigation 
      risks associated with handling Protected Health Information and stringent 
      health data privacy regulations; 
 
   -- the Company's near-term consumer hardware revenues are concentrated 
      within a single brand license with Reebok; 
 
   -- the Company's reported revenue and gross margins are subject to 
      volatility from retail channel sell-through trends, return provisions, 
      price protections, and variable consideration adjustments; 
 
   -- the Company is at risk to possible hidden or contingent liabilities, 
      including pending litigation, regulatory non-compliance, or cybersecurity 
      vulnerabilities incurred by its recent acquisition of Somatix; 
 
   -- in connection with the Somatix acquisition, a substantial amount of 
      goodwill and intangible assets will likely be recognized and is at risk 
      of impairment; 
 
   -- the Company may require additional funds by way of debt or equity 
      financings to continue to fund its operating, investing, and financing 
      activities; 
 
   -- the Company may continue to experience negative impacts of global supply 
      constraints; 
 
   -- the Company has limited financial resources, a working capital deficiency 
      and a history of negative cash flow, including negative cash flow from 
      operating activities, and may require additional funds by way of debt or 
      equity financings to continue to fund its operating, investing, and 
      financing activities; 
 
   -- the Company is at risk of not being able to settle its debt obligations 
      or to extend, replace, or refinance its existing debt obligations on 
      terms reasonably acceptable to the Company, or at all; 
 
   -- global operations risks including unexpected changes in foreign 
      governmental laws, policies, regulations or project locations concerning 
      the import and export of goods, services and technology, and exposure to 
      global credit and financial factors on consumers in the Company's areas 
      of operations; 
 
   -- the Company cannot guarantee that it will become cash-flow positive or 
      profitable, and negative cash flow or the failure to become profitable in 
      any future fiscal period could result in an adverse material change to 
      the Company; 
 
   -- the Company relies on third party manufacturing and from time to time 
      there may be product defects caused by the manufacturing process, 
      assembly, or engineering, particularly when first introduced or when new 
      versions are released 
 
   -- global manufacturing risks including the risk that products manufactured 
      by the Company may be subject to changing tariffs applied by selling 
      countries to countries of origin with little or no warning due to the 
      Company's use of factories in China, Vietnam, Taiwan, or Malaysia, from 
      time to time; 
 
   -- the Company's revenues may vary over time and with seasonality; 
 
   -- the Company may not generate sufficient revenue to sustain operations; 
 
   -- the Company may not be able to successfully negotiate contracts to source, 
      develop, manufacture, pack, ship, distribute, or sell products 
      economically, if at all; 
 
   -- the Company relies on major components to be manufactured on an original 
      equipment manufacturer basis, which involves several risks, including the 
      possibility of defective products, a shortage of components, delays in 
      delivery schedules, and increases in component costs; 
 
   -- demand for international sales may not grow as expected or at all, and 
      there is no assurance that the Company will succeed in expanding into new 
      markets; 
 
   -- the ability of the Company to successfully enter new markets is subject 
      to uncertainties; 
 
   -- there can be no assurance that the business and growth strategy of the 
      Company will enable the Company to be profitable; 
 
   -- the Company relies on licenses from third parties, and there can be no 
      assurance that these third-party licenses will continue to be available 
      to the Company on commercially reasonable terms, or at all; 
 
   -- the Company may be required to obtain and maintain certain permits, 
      licenses, and approvals in the jurisdictions where its products or 
      technologies are being commercialized or sold, and there can be no 
      assurances that the Company will be able to obtain or maintain any such 
      necessary licenses, permits, or approvals; 
 
   -- the future growth and profitability of the Company may be dependent in 
      part on the effectiveness and efficiency of its sales and marketing 
      expenditures; 
 
   -- the Company may be exposed to product liability claims in the use of its 
      products; 
 
   -- the market for the Company's products is characterized by rapidly 
      changing technology, evolving industry standards, and customer 
      requirements, which may cause the introduction of products embodying new 
      technology and the emergence of new industry standards to render the 
      existing technology solutions of the Company obsolete or unmarketable, 
      and may also exert price pressures on the Company's existing solutions; 
 
   -- the Company may not be able to develop new market relevant products in a 
      timely manner; 
 
   -- the ability of the Company to generate revenue will largely depend upon 
      the effectiveness of its sales and marketing efforts, both domestically 
      and internationally; 
 
   -- the success of the Company is largely dependent on the performance of its 
      key directors, officers, and employees; 
 
   -- the commercial success of the Company is reliant on the ability to 
      develop new or improved technologies, manufacture products, and to 
      successfully obtain patents or other proprietary or statutory protection 
      for these technologies and products in Canada and other jurisdictions; 
 
   -- the Company could become subject to a wide variety of cyberattacks on its 
      networks and systems; 
 
   -- the Company is engaged in an industry that is highly competitive and 
      rapidly evolving; 
 
   -- the new products provided by the competitors of the Company may render 
      the existing products of the Company less competitive; 
 
   -- the Company uses contract manufacturers to manufacture its products and 
      products under development and its reliance on contract manufacturers 
      subjects it to significant operational risks, many of which would impair 
      its ability to deliver products to its customers should they occur; 
 
   -- the Company may become party to litigation, mediation, or arbitration 
      from time to time in the ordinary course of business; 
 
   -- any future acquisitions may result in significant transaction expenses 
      and may present additional risks associated with entering new markets, 
      offering new products, and integrating the acquired companies; 
 
   -- the business plan of the Company anticipates rapid growth, and the 
      Company may not be able to continue to attract, hire, and retain the 
      highly skilled and motivated officers and employees necessary to manage 
      its growth effectively; 
 
   -- the computer infrastructure of the Company may potentially be vulnerable 
      to physical or electronic computer break-ins, viruses, and similar 
      disruptive problems and security breaches; 
 
   -- the Company may not be able to enhance its current products or develop 
      new products at competitive prices or in a timely manner; 
 
   -- the Company is subject to taxes in Canada and other foreign jurisdictions, 
      and in the ordinary course of business, there may be many transactions 
      and calculations where the ultimate tax determination is uncertain; 
 
   -- a customer of the Company or counterparty to a financial instrument of 
      the Company may fail to meet its contractual obligations to the Company; 
 
   -- the ability of the Company to manage growth effectively will require it 
      to continue to implement and improve its operational and financial 
      systems, which may not always be possible; 
 
   -- the forecasts and models of the Company could be inaccurate; 
 
   -- the accounting estimates and judgments of the Company could be incorrect; 
 
   -- the Company may fail to develop or maintain effective controls over 
      financial reporting; 
 
   -- there is no assurance that insurance will be consistently available to 
      the Company on economic terms, if at all; and 
 
   -- the risk factors included in the Company's other continuous disclosure 
      documents available on SEDAR+ at www.sedarplus.ca. 

Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date of this press release, and to not use such forward-looking information other than for its intended purpose. Vitalist undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities law.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment